| | Breast density category | value test | I | II | III | IV | | | | | | | | |
| Menopause | | | | | | | | | Fisher: <0.001 | Yes | 90 | 16.3% | 273 | 49.4% | 171 | 30.9% | 19 | 3.4% | | No | 11 | 2.3% | 117 | 24.0% | 306 | 62.7% | 54 | 11.1% | Total | 101 | 9.7% | 390 | 37.5% | 477 | 45.8% | 73 | 7.0% |
| Breastfeeding | | | | | | | | | : 0.181, Fisher: 0.176 | Yes | 57 | 10.4% | 221 | 40.5% | 236 | 43.2% | 32 | 5.9% | | No | 41 | 9.7% | 144 | 34.2% | 206 | 48.9% | 30 | 7.1% | | Total | 102 | 10.1% | 393 | 37.7% | 481 | 45.7% | 73 | 6.4% | |
| Parity | | | | | | | | | Fisher: <0.001 | 0 | 15 | 7.7% | 56 | 28.7% | 103 | 52.8% | 21 | 10.8% | | 1 | 4 | 5.3% | 23 | 30.3% | 45 | 59.2% | 4 | 5.3% | 2 | 16 | 6.3% | 92 | 36.1% | 128 | 50.2% | 19 | 7.5% | 3 | 32 | 12.3% | 103 | 39.5% | 113 | 43.3% | 13 | 5.0% | 4 | 17 | 14.7% | 53 | 45.7% | 42 | 36.2% | 4 | 3.4% | 5 | 6 | 14.6% | 24 | 58.5% | 11 | 26.8% | 0 | 0.0% | 6 | 5 | 26.3% | 9 | 47.4% | 4 | 21.1% | 1 | 5.3% | 7 | 2 | 40.0% | 2 | 40.0% | 1 | 20.0% | 0 | 0.0% | 8 | 2 | 66.7% | 1 | 33.3% | 0 | 0.0% | 0 | 0.0% | 9 | 0 | 0.0% | 2 | 100.0% | 0 | 0.0% | 0 | 0.0% | Total | 99 | 10.2% | 365 | 37.5% | 447 | 45.9% | 62 | 6.4% |
| Parity cut-off | | | | | | | | | Fisher: <0.001 | ≤1 | 19 | 7.0% | 79 | 29.2% | 148 | 54.6% | 25 | 9.2% | | >1 | 80 | 11.4% | 286 | 40.7% | 299 | 42.6% | 37 | 5.3% | |
| HRT in postmenopausal women | | | | | | | | | Fisher: 0.829 | No | 80 | 16.4% | 241 | 49.5% | 148 | 30.4% | 18 | 3.7% | | Yes | 10 | 15.2% | 32 | 48.5% | 23 | 34.8% | 1 | 1.5% | |
| Breast cancer | | | | | | | | | Fisher: 0.567 | Yes | 15 | 12.5% | 44 | 36.7% | 51 | 42.5% | 10 | 8.3% | | No | 87 | 9.4% | 349 | 37.6% | 430 | 46.3% | 63 | 6.8% | | Total | 102 | 9.7% | 393 | 37.5% | 481 | 45.9% | 73 | 7.0% | |
| Family history of breast cancer | | | | | | | | Fisher: 0.124 | Yes | 25 | 8.6% | 105 | 36.0% | 133 | 45.5% | 29 | 9.9% | | No | 77 | 10.2% | 288 | 38.0% | 348 | 46.0% | 44 | 5.8% | | Total | 102 | 9.7% | 393 | 37.5% | 481 | 45.9% | 73 | 7.0% | |
| Risk assessment of breast cancer | | | | | | | | | Fisher: 0.293 | No | 77 | 10.2% | 288 | 38.0% | 348 | 46.0% | 44 | 5.8% | | Low | 11 | 8.8% | 44 | 35.2% | 55 | 44.0% | 15 | 12.0% | | Moderate | 13 | 10.7% | 44 | 36.1% | 56 | 45.9% | 9 | 7.4% | | High | 1 | 2.2% | 17 | 37.8% | 22 | 48.9% | 5 | 11.1% | | Total | 102 | 9.7% | 393 | 37.5% | 481 | 45.9% | 73 | 7.0% | |
| BI-RADS final report classification | | | | | | | | | Fisher: 0.056 | 0 | 0 | 0.0% | 3 | 37.5% | 3 | 37.5% | 2 | 25.0% | | 1 | 22 | 17.5% | 47 | 37.3% | 54 | 42.9% | 3 | 2.4% | | 2 | 68 | 9.6% | 261 | 36.7% | 335 | 47.1% | 47 | 6.6% | | 3 | 9 | 5.6% | 64 | 40.0% | 69 | 43.1% | 18 | 11.3% | | 4 | 2 | 5.9% | 14 | 41.2% | 16 | 47.1% | 2 | 5.9% | | 5 | 1 | 12.5% | 3 | 37.5% | 3 | 37.5% | 1 | 12.5% | | 6 | 0 | 0.0% | 1 | 50.0% | 1 | 50.0% | 0 | 0.0% | | Total | 102 | 9.7% | 393 | 37.5% | 481 | 45.9% | 73 | 7.0% | |
| Screening type statistics | No dense breast (, %) | Dense breast (, %) | : 0.634 | Categories 0, 3, 4, 5 | 96 | 45.7% | 114 | 54.3% | | Categories 1, 2 | 398 | 47.6% | 439 | 52.4% | |
| Diagnostic type statistics | No dense breast (, %) | Dense breast (, %) | Fisher: 0.962 | Categories 4, 5 | 20 | 47.6% | 22 | 52.4% | | Categories 1, 2, 3 | 471 | 47.2% | 526 | 52.8% | |
| 0 versus 1, 2, 3, 4, 5 | No dense breast (, %) | Dense breast (, %) | Fisher: 0.729 | Categories 0 | 3 | 37.5% | 5 | 62.5% | | Categories 1, 2, 3, 4, 5 | 491 | 47.3% | 548 | 52.7% | |
|
|